ACSM2A | Acyl-CoA synthetase medium-chain family member 2A | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
KNG1 | Kininogen 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AFM | Afamin | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
HAO2 | Hydroxyacid oxidase 2 (long chain) | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
SLC22A7 | Solute carrier family 22 (organic anion transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CYP4A22 | Cytochrome P450, family 4, subfamily A, polypeptide 22 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
CYP4A11 | Cytochrome P450, family 4, subfamily A, polypeptide 11 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
BHMT | Betaine--homocysteine S-methyltransferase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ACSM2B | Acyl-CoA synthetase medium-chain family member 2B | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CYP3A4 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
PRODH2 | Proline dehydrogenase (oxidase) 2 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
HPD | 4-hydroxyphenylpyruvate dioxygenase | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Group enriched |
CREB3L3 | CAMP responsive element binding protein 3-like 3 | Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Group enriched |
C4BPA | Complement component 4 binding protein, alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ALDH8A1 | Aldehyde dehydrogenase 8 family, member A1 | Predicted intracellular proteins
| | | | | Group enriched |
CYP2D6 | Cytochrome P450, family 2, subfamily D, polypeptide 6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
UGT1A5 | UDP glucuronosyltransferase 1 family, polypeptide A5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
CYP1A1 | Cytochrome P450, family 1, subfamily A, polypeptide 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FTCD | Formimidoyltransferase cyclodeaminase | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
UGT1A8 | UDP glucuronosyltransferase 1 family, polypeptide A8 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CPS1 | Carbamoyl-phosphate synthase 1, mitochondrial | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
DAO | D-amino-acid oxidase | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
GOLGA6B | Golgin A6 family, member B | Predicted intracellular proteins
| | | | | Group enriched |
PROZ | Protein Z, vitamin K-dependent plasma glycoprotein | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
DIO1 | Deiodinase, iodothyronine, type I | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
AGXT2 | Alanine--glyoxylate aminotransferase 2 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Group enriched |
DPYS | Dihydropyrimidinase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
TM4SF4 | Transmembrane 4 L six family member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
UPB1 | Ureidopropionase, beta | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
MTTP | Microsomal triglyceride transfer protein | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
C4BPB | Complement component 4 binding protein, beta | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
DMGDH | Dimethylglycine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
APOM | Apolipoprotein M | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GCGR | Glucagon receptor | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Group enriched |
CLDN14 | Claudin 14 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CUX2 | Cut-like homeobox 2 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Group enriched |
DNMT3L | DNA (cytosine-5-)-methyltransferase 3-like | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
MOGAT2 | Monoacylglycerol O-acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |